Insider Transactions in Q3 2023 at Supernus Pharmaceuticals, Inc. (SUPN)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2023
|
Jack A. Khattar President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,804
-1.9%
|
$537,728
$32.1 P/Share
|
|
Sep 07
2023
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+3.81%
|
-
|
|
Sep 07
2023
|
Padmanabh P. Bhatt Sr. VP of IP, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,182
-14.16%
|
$37,824
$32.1 P/Share
|
|
Sep 07
2023
|
Padmanabh P. Bhatt Sr. VP of IP, CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+23.05%
|
-
|
|
Aug 30
2023
|
Tami Tillotson Martin Sr. V.P., Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
8,100
-8.68%
|
$259,200
$32.0 P/Share
|
|
Aug 30
2023
|
Tami Tillotson Martin Sr. V.P., Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
8,100
+7.98%
|
$186,300
$23.99 P/Share
|
|
Aug 25
2023
|
Tami Tillotson Martin Sr. V.P., Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
5,135
-5.68%
|
$159,185
$31.59 P/Share
|